Larson Financial Group LLC cut its holdings in GSK plc (NYSE:GSK – Free Report) by 52.7% during the fourth quarter, according ...
1h
Zacks Investment Research on MSNWhy GSK (GSK) is a Top Momentum Stock for the Long-TermFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
Pharmaceutical industry leaders, under the aegis of Association of Industrial Pharmacists of Nigeria (NAIP), have raised ...
Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...
LONDON - Two British diplomats expelled in a spying row. A blistering statement from Russia's foreign intelligence service ...
Treatment-experienced patients with moderate to severe atopic dermatitis attained higher efficacy rates on rocatinlimab ...
A century ago, measles was killing a thousand people in the U.S. every year. By 2000, vaccines had all but eliminated the ...
Haleon Sri Lanka formerly known as GlaxoSmithKline Healthcare; the first multinational pharmaceutical manufacturing ...
Explore the Cancer Vaccines Market size, share, trends, and growth forecast. Learn about key industry players, advancements, and future opportunities in oncology ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results